Skip to content
  • Tuesday, 27 October 2026
  • 11:25 pm
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • AbbVie Secures Up to $745 Million in Pain Pipeline Deal with Chinese Biopharma Haisco
Pharmaceutical R&D

AbbVie Secures Up to $745 Million in Pain Pipeline Deal with Chinese Biopharma Haisco

Teuku Ryan Apr 13, 2026 0

AbbVie, a global biopharmaceutical giant, has finalized a significant strategic collaboration with Haisco Pharmaceutical Group, a prominent Chinese biopharmaceutical company.…

Read More
Molecular & Cell Biology

This crocodile ran like a greyhound across prehistoric Britain 200 million years ago

Angie Faith Apr 12, 2026 0

Scientists have unearthed a remarkable new species of ancient crocodile relative, unearthed from the fossil-rich deposits of Gloucester, United Kingdom.…

Read More
Pharmaceutical R&D

Everest Medicines Acquires Hasten Biopharmaceuticals for $250 Million to Bolster Asia Pacific Chronic Disease Portfolio and Commercial Reach

Teuku Ryan Apr 9, 2026 0

Everest Medicines, a leading biopharmaceutical company focused on developing and commercializing innovative medicines for chronic diseases, has announced a significant…

Read More
Pharmaceutical R&D

Sidewinder Therapeutics Secures $137 Million in Series B Financing to Advance Bispecific Antibody-Drug Conjugate Pipeline

Teuku Ryan Apr 8, 2026 0

Sidewinder Therapeutics has announced the successful closure of a substantial $137 million Series B financing round, a significant development signaling…

Read More
Pharmaceutical R&D

Apnimed Secures Up to $150 Million in Credit Facility to Fuel Potential US Launch of Obstructive Sleep Apnea Therapy AD109

Teuku Ryan Apr 7, 2026 0

Boston, MA – – Apnimed, a clinical-stage biopharmaceutical company focused on developing novel therapies for sleep-related breathing disorders, has announced…

Read More
Pharmaceutical R&D

Canada Invests C$79 Million in Aspect Biosystems to Accelerate Development of Bioengineered Cellular Medicines for Endocrine and Metabolic Diseases

Teuku Ryan Apr 6, 2026 0

Vancouver, BC – Aspect Biosystems, a pioneering company in the field of bioengineered cellular medicines, has received a significant C$79…

Read More
Molecular & Cell Biology

This crocodile ran like a greyhound across prehistoric Britain 200 million years ago

Angie Faith Apr 5, 2026 0

Ancient Swift-Footed Predator Unearthed in Triassic Britain: A Glimpse into Pre-Extinction Ecosystems In a remarkable discovery that sheds new light…

Read More
Clinical Diagnostics & Pathology

Vitestro Secures $70 Million in Oversubscribed Series B to Accelerate Autonomous Phlebotomy Development and Global Commercialization

Reynand Amr Wu Mar 29, 2026 0

Utrecht, Netherlands – Vitestro, a pioneering medical robotics company, has successfully closed an oversubscribed Series B financing round, securing an…

Read More
Pharmaceutical R&D

Earendil Labs Secures $787 Million to Accelerate AI-Driven Drug Discovery and Expand Robust Pipeline

Teuku Ryan Mar 23, 2026 0

Earendil Labs, a burgeoning biotechnology firm at the forefront of artificial intelligence (AI)-powered drug discovery, has announced a significant financial…

Read More
Clinical Diagnostics & Pathology

Vitestro Secures $70 Million to Revolutionize Blood Collection with Autonomous Robotic Phlebotomy, Poised for Global Expansion

Reynand Amr Wu Mar 22, 2026 0

Vitestro, a pioneering Dutch medical robotics company, has successfully closed an oversubscribed Series B financing round, securing an impressive $70…

Read More

Posts pagination

1 … 4 5 6
A Surprising Discovery on a Baltic Island Rewrites the Ancient Human-Wolf RelationshipStanford Researchers Reveal Glucose as a Master Regulator of Tissue Differentiation and Gene ExpressionUniversity of Manchester Scientists Lead Discovery of New Subatomic Particle at CERN’s Large Hadron ColliderA Century of Scientific Inquiry: The Enduring Legacy and Evolution of Science News
The Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals PlummetJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactEliquis Loss of Exclusivity: A Pharmaceutical Patent Cliff of Historic ProportionsMEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric Growth
Merck and Moderna’s cancer vaccine is customized for each patient’s tumorAn Unbiased Look at Google Gemini Omni: Features, Costs, and Market ComparisonESMO 2026: Sacituzumab Tirumotecan Sets New Survival Benchmark in Recurrent Endometrial CancerLight-Driven Magnetism Breakthrough Promises Ultrafast, High-Density Digital Data Storage
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Merck and Moderna’s cancer vaccine is customized for each patient’s tumor
Lana Keisha Oct 27, 2026
Data Science & Bioinformatics
An Unbiased Look at Google Gemini Omni: Features, Costs, and Market Comparison
Evan Lee Salim Oct 27, 2026
Pharmaceutical R&D
ESMO 2026: Sacituzumab Tirumotecan Sets New Survival Benchmark in Recurrent Endometrial Cancer
Teuku Ryan Oct 27, 2026
Advanced Materials Science
Light-Driven Magnetism Breakthrough Promises Ultrafast, High-Density Digital Data Storage
Nila Kartika Wati Oct 27, 2026

Copyright © 2026 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ